Bial Showcases Parkinson’s Research at MDS 2026

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, is presenting 16 scientific posters at the International Congress of Parkinson’s Disease and Movement Disorders (MDS 2026), taking place in...
Anglais

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at...
Anglais
10/05/2026 10:00
Anaeco Secures Strategic Investment from Momentum Global Ventures to Accelerate Commercial Deployment

Anaeco, Inc., a clean technology company developing systems to destroy harmful and difficult-to-abate gases, today announced a strategic investment from Momentum Global Ventures. The investment supports Anaeco as it moves from technology development and validation to commercial deployment across three initial markets: anesthetic gases, refrigerants, and semiconductor manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202610...

Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

Vertex Pharmaceuticals Incorporated(Nasdaq: VRTX) today announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-mediated kidney disease (AMKD) and modest proteinuria and in people...
Anglais

Amazfit Introduces T-Rex Dual Solar, the First AMOLED Smartwatch with Dual-Sided Solar Charging

Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Dual Solar , a premium expedition smartwatch built for long-distance and multi-day exploration. Launching on the autumnal equinox — a day defined by the balance of sunlight and darkness — the T-Rex Dual Solar is the world’s first AMOLED smartwatch featuring a dual-sided solar charging system, combining solar...
Anglais

Saildrone USVs Receive Danish Flag Registration for European Operations

Saildrone today announcedthat the first four Saildrone Voyager USVs (unmanned surface vehicles) have been registered in Denmark and will operate under the Danish flag, marking the first time Saildrone USVs...
Anglais
Subscribe to